Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
about
Validation and calibration of structural models that combine information from multiple sources.Estimating progression rates for human papillomavirus infection from epidemiological data.A cost-utility analysis of cervical cancer vaccination in preadolescent Canadian females.Cost-effectiveness of different human papillomavirus vaccines in SingaporeIncreasing rates of cervical cancer in young women in England: an analysis of national data 1982-2006.Efficacy of vaccination against HPV infections to prevent cervical cancer in France: present assessment and pathways to improve vaccination policiesInference of type-specific HPV transmissibility, progression and clearance rates: a mathematical modelling approachA generally applicable cost-effectiveness model for the evaluation of vaccines against cervical cancer.Cost-effectiveness of cervical cancer screening with human papillomavirus DNA testing and HPV-16,18 vaccination.The Dynamics of HPV Infection and Cervical Cancer Cells.Estimating the number needed to vaccinate to prevent diseases and death related to human papillomavirus infection.Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis.Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort studyEconomic evaluation of human papillomavirus vaccination in the United Kingdom.Calibration of complex models through Bayesian evidence synthesis: a demonstration and tutorial.Prophylactic human papillomavirus vaccines: potential for sea change.Modeling cervical cancer prevention in developed countries.Ethnic differences in human papillomavirus awareness and vaccine acceptability.Economic evaluations of human papillomavirus vaccines.The cost effectiveness of human papillomavirus vaccines: a systematic review.HPV prevalence and type-distribution in cervical cancer and premalignant lesions of the cervix: A population-based study from Northern Ireland.Cost-effectiveness of human papillomavirus vaccination in Germany.Uptake of the HPV vaccination programme in England: a cross-sectional survey of young women attending sexual health services.The impact of cytology screening and HPV vaccination on the burden of cervical cancer.Incorporating calibrated model parameters into sensitivity analyses: deterministic and probabilistic approaches.Human papillomavirus vaccination and social inequality: results from a prospective cohort study.Impact of HPV vaccination with Gardasil® in Switzerland.
P2860
Q30239838-DE0A9F05-B966-4DFA-9595-7363BB42972EQ33467330-229B5E2C-23FB-4E94-BADE-154AD2342848Q33514126-AB134E73-3B4F-4E89-BA46-221A43E82B66Q33859018-47664D10-934B-4EB5-B4CF-BFD7DB3E468CQ33926729-DB4B7791-752C-4AC1-9759-A0DB528336F8Q34199773-1170F946-DBD5-42E4-B78D-CF328E80B805Q34490267-7306AE09-6402-49EF-8E9A-4D81D6451FFBQ34733919-62A7FD0A-6D96-4318-BD4B-32044FA3F6B3Q34997604-39C10889-0323-4E3A-A318-96BECF2712E7Q35871191-0615E775-3604-4BDC-ABFB-BF34323779EFQ35944640-AADC494D-66F4-4BBD-BD48-9A856A2698DEQ36534239-1DC13AFD-4C4C-4E05-8CC6-959F4A0A02F7Q36645631-42C91983-C6F0-45B7-B0EF-D0F23574496AQ36818045-F17DFCB6-D713-402A-9F5B-2CA69A0883E9Q36843345-A47157CC-4E6D-49ED-AB5A-2392FFDF4141Q36899064-8C0D0F63-0D3E-412A-B14A-F3FC4BE824F2Q37291448-10B45336-55A0-45A9-ADF3-8EDDF3ABADFDQ37651626-BDEBD5E1-69FE-4933-8F59-6101439BE590Q37763114-11E369FD-FEF0-4987-AEEC-A75E92DB43C3Q37993109-90D08067-3B4D-4842-AAE1-040F6A27AF3BQ38930783-8043FBCC-5EEC-41E5-9530-78372D61EC37Q40063569-90A3A1C5-FA0E-4ED4-9ED9-627E03627207Q42230928-7C0F354D-CBF9-481D-B06F-5222552F5FACQ45069015-4BC29843-D04C-424A-B2FD-D21B39E63AEAQ46659871-D5E788D3-55DB-42C2-A3B1-FB736B4B75D9Q46690667-79FBE5F9-8C92-40A1-AE4F-03B5139B842CQ47257772-8AA8E4D7-A7F3-48D6-90C8-F6BEF1CA2307
P2860
Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Estimating the long-term impac ...... n of cervical cancer in the UK
@ast
Estimating the long-term impac ...... n of cervical cancer in the UK
@en
type
label
Estimating the long-term impac ...... n of cervical cancer in the UK
@ast
Estimating the long-term impac ...... n of cervical cancer in the UK
@en
prefLabel
Estimating the long-term impac ...... n of cervical cancer in the UK
@ast
Estimating the long-term impac ...... n of cervical cancer in the UK
@en
P2093
P2860
P356
P1476
Estimating the long-term impac ...... n of cervical cancer in the UK
@en
P2093
C Sherlaw-Johnson
M Drummond
S Gallivan
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603501
P407
P577
2006-12-05T00:00:00Z